Clinical Trial

Myval Global Study of Myval™ THV Series Implanted in Patients With Native Severe Aortic Valve Stenosis.

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 4, 2024 (before its estimated May 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
A retrospective, multinational, multicentre, observational study in patients presenting with native severe aortic valve stenosis and treated with Myval™ Transcatheter Heart Valve Series in real-world setting.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-01-08; most recent amendment 2024-02-29.
Trial Details
NCT Number NCT04703699
Lead Sponsor Meril Life Sciences Pvt. Ltd.
Conditions Aortic Valve Stenosis
Enrollment 200 participants
Start Date 2020-08-07
Primary Completion 2024-05-30 (estimated)
Study Completion 2028-11-30 (estimated)
Updated on ClinicalTrials.gov 2024-03-04